Details of the Drug

General Information of Drug (ID: DMZBU2M)

• Drug Name: Triazavirin
• Synonyms: Riamilovir; Riamilovir [INN]; Triazavirin [WHO-DD]

Indication

Disease Entry	ICD 11	Status	REF
Influenza virus infection	1E30-1E32	Phase 2	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Investigative	[2]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C5H4N6O3S
  Canonical SMILES: CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-]
  InChI: 1S/C5H4N6O3S/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5/h1H3,(H,6,8,9)
  InChIKey: IDVQGNMSSHPZSJ-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 3113817
  CAS Number: 123606-06-4
  TTD ID: D07IYO
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] A New Antiviral Drug Triazavirin: Results of Phase II Clinical Trial. Vopr Virusol. Nov-Dec 2012;57(6):9-12.
• [2] China Tests Russian Antiviral Drug Which Might Treat Coronavirus As Moscow Warns Of Possible Mass Outbreak. February 5, 2020